Amgenbd

Amgen is a biotechnological company that is focused on discovering, developing and manufacturing therapeutics for serious illnesses.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Industries / Tags:

Detailed Amgenbd Information

Geographic Data

Amgenbd headquarters map

Address:

City:

State:

Zip:

Country:

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

2,886,040Website Global Rank

5,858Website Monthly Traffic

Twitter Followers

Description

Amgen is a biotechnological company that is focused on discovering, developing and manufacturing therapeutics for serious illnesses.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
6/2022 Code Biotherapeutics Series A 0
8/2010 TetraLogic Pharmaceuticals Series C 0
9/2019 Nkarta Therapeutics Series B 114M
11/2009 Trinity Biosystems Debt Financing 7.5M
3/2023 QurAlis Series B 0
3/2007 Theraclone Sciences Series B 29M
1/2016 Tizona Therapeutics Series A 27M
10/2007 Allozyne Series B 30M
12/2005 Allozyne Series A 3.5M
3/2013 Theraclone Sciences Series B 0
3/2010 Theraclone Sciences Venture Round 1.5M
10/2009 Epizyme Series B 32M
5/2021 GPB Scientific Venture Round 0
9/2021 Obsidian Therapeutics Series B 0
11/2014 Ziarco Series B 33M
1/2021 Senti Biosciences Series B 105M
8/2021 Genome Medical Series C 0
7/2014 NexImmune Venture Round 3M
5/2021 Hummingbird Bioscience Series C 0
4/2017 Science 37 Series C 35M
3/2022 Celsius Therapeutics Series B 0
5/2018 Akili Interactive Labs Series C 0
5/2021 Akili Interactive Labs Series D 0
4/2018 Aetion Series B 36.4M
1/2022 Gandeeva Therapeutics Series A 0
5/2012 Gamida Cell Series E 0
1/2004 Infinity Pharmaceuticals Venture Round 25M
5/2020 Syapse Series D 30M
12/2017 Obsidian Therapeutics Series A 0
7/2022 Kernal Biologics Series A 0
7/2018 Alector Series E 133M
5/2015 Precision BioSciences Series A 0
1/2021 NoviSci Seed Round -
11/2017 Syapse Series D 0
7/2015 Ra Pharmaceuticals Series B 58.5M
2/2015 Viridian Therapeutics Series B 0
6/2010 Calistoga Pharmaceuticals Series C 40M
3/2007 Calistoga Pharmaceuticals Series A 21M
3/2016 Tizona Therapeutics Series B 43M
6/2009 Viridian Therapeutics Series A 4M
8/2021 Catena Biosciences Pre Seed Round 0
10/2017 Kymera Therapeutics Series A 30M
8/2011 Ardelyx Series B 30M
2/2018 Senti Biosciences Series A 53M
1/2008 Calistoga Pharmaceuticals Series A 5.2M
3/2022 CancerIQ Series B 14M
5/2009 Calistoga Pharmaceuticals Series B 30M
8/2007 Accelerator Corp. Series C 22.5M
1/2011 TetraLogic Pharmaceuticals Series C 0
8/2017 GNS Healthcare Venture Round 6M
12/2013 Sutro Biopharma Series D 0
7/2005 Integrated Diagnostics Series A -
7/2006 Trinity Biosystems Series B 21M
4/2019 NAVAN Technologies Seed Round -
1/2014 Atara Biotherapeutics Series B 13.5M
6/2007 Argolyn Bioscience Series A 15.8M
5/2022 TileDB Venture Round -
3/2020 GPB Scientific Venture Round 25.5M
1/2004 ViaCell Venture Round 20M
5/2012 Sutro Biopharma Series C 16.5M
9/2010 DecImmune Therapeutics Venture Round 3.2M
7/2018 Sutro Biopharma Series E 0
9/2022 ImmunoScape Venture Round 14M
7/2022 BigHat Biosciences Series B 0
7/2020 BeiGene Post-IPO Equity 2.1B
11/2004 Accelerator Corp. Venture Round 0
4/2021 ImmunoSCAPE Venture Round 14M
9/2020 Carmot Therapeutics Series C 47M
5/2005 Avidia Series B 28.5M
8/2011 Oncofactor Series A 2.1M
3/2006 Theraclone Sciences Series A 0
1/2011 Acylin Therapeutics Series A 4.4M
6/2018 Precision BioSciences Series B 0
8/2008 InteKrin Series C 0
11/2018 Kymera Therapeutics Series B 65M
2/2020 EnClear Therapies Series A 0
11/2018 Caraway Therapeutics Series A 23M
5/2020 QurAlis Series A 0
10/2014 Imago BioSciences Series A 26.5M
11/2020 Imago BioSciences Series C 80M
3/2019 Imago BioSciences Series B 40M
6/2022 ReCode Therapeutics Series B 0
7/2019 GNS Healthcare Series D 23M
4/2018 QurAlis Seed Round -
12/2020 DJS Antibodies Venture Round 0
7/2016 Akili Interactive Labs Series B 42.4M
11/2010 Sutro Biopharma Series C 36.5M
6/2006 TetraLogic Pharmaceuticals Series B 36M
1/2015 Surface Oncology Series A 35M
5/2017 Genuity Science Series B 75M
11/2005 PTC Therapeutics Private Equity Round 26.6M
10/2022 Inversago Pharma Series C 0
4/2012 Viridian Therapeutics Series B 20M
11/2018 Ribometrix Series A 30M
5/2022 Olive Diagnostics Seed Round 1.5M
11/2018 QurAlis Seed Round 5.5M
3/2012 Cytos Post-IPO Equity 40M
10/2013 Opsona Series C 0
11/2017 Fortuna Fix Series B 25M
4/2013 Opsona Series C 0
12/2013 Atara Biotherapeutics Series B 38.5M
6/2014 Viridian Therapeutics Series B 7M
11/2022 Casma Therapeutics Series C 46M
8/2021 Catena Biosciences Seed Round 5M
1/2016 Alector Series D 29.5M
9/2011 Theraclone Sciences Series B 10.6M
6/2006 VLST Corporation Series B 55M
5/2006 Avidia Series C 43.8M
6/2022 Senti Biosciences Post-IPO Equity 0
2/2019 Aetion Series B 0
7/2022 BigHat Biosciences Series B 0
7/2022 Kernal Biologics Series A 0
6/2022 ReCode Therapeutics Series B 0
6/2022 Senti Biosciences Post-IPO Equity 0
6/2022 Code Biotherapeutics Series A 0
5/2022 TileDB Venture Round -
3/2022 Celsius Therapeutics Series B 0
3/2022 CancerIQ Series B 0
1/2022 Gandeeva Therapeutics Series A 0
9/2021 Obsidian Therapeutics Series B 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research